Canada Pension Plan Investment Board
OBIO icon

Canada Pension Plan Investment Board’s Orchestra BioMed OBIO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48K Buy
11,300
+4,200
+59% +$17.9K ﹤0.01% 1673
2025
Q4 		$29.5K Buy
+7,100
New +$28.6K ﹤0.01% 1930

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Canada Pension Plan Investment Board's OBIO Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Orchestra BioMed (OBIO) stake by 59% in Q1 2026, buying an estimated $17.9K and bringing the position to 11,300 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

Canada Pension Plan Investment Board first reported a position in OBIO in Q4 2025 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold OBIO as of Q1 2026.

  • Canada Pension Plan Investment Board held 11,300 shares of Orchestra BioMed worth $48K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 4,200 Orchestra BioMed shares in Q1 2026, an estimated $17.9K.
  • Orchestra BioMed made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1673 holding.
  • Canada Pension Plan Investment Board first reported a position in Orchestra BioMed in Q4 2025 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Orchestra BioMed as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.